Journals / Turkish Neurosurgery / 2015 / Cilt: 25 - Sayı: 2

ıncrease in Folate receptor Alpha expression in nonfunctional Pituitary Adenomas

Fonksiyonel Olmayan Hipofiz Adenomlarında Folat Reseptörü Alfa Ekspresyonunda Artış

Pages
298–304
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

CoNClusIoN: These results suggest that the overexpression of folate receptor alpha mRNA and protein by nonfunctional pituitary adenomas may facilitate the growth of these tumours.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:AIm: Human pituitary adenomas account for 10% of intracranial tumours and occur in about 20% of the population.
📊
Key Findings & Data:REsulTs: We found folate receptor alpha mRNA and protein were significantly upregulated in clinically nonfunctional pituitary adenomas compared to functional tumours.
💡
Conclusion & Impact:CoNClusIoN: These results suggest that the overexpression of folate receptor alpha mRNA and protein by nonfunctional pituitary adenomas may facilitate the growth of these tumours.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

AIm: Human pituitary adenomas account for 10% of intracranial tumours and occur in about 20% of the population. They cause hypopituitarism or the compression of adjacent regional structures. However, little is known about the molecular pathogenesis that contributes to the development of these tumours. mATERIAl and mEThods: In this study, we investigated the relationship between the expression level of folate receptor alpha and some clinical factors (endocrine, age, gender, repeated operation or not, mean diameter of tumour and invasiveness) of pituitary adenomas. Realtime fluorescent quantitative reverse transcriptase polymerase chain reaction was used to determine the expression of folate receptor alpha mRNA in pituitary adenomas and normal pituitaries. Folate receptor alpha protein levels were quantified using Western blot analysis and Immunohistochemistry. REsulTs: We found folate receptor alpha mRNA and protein were significantly upregulated in clinically nonfunctional pituitary adenomas compared to functional tumours. For nonfunctional tumours, folate receptor alpha expression was much higher in the invasive group than in non-invasive group. CoNClusIoN: These results suggest that the overexpression of folate receptor alpha mRNA and protein by nonfunctional pituitary adenomas may facilitate the growth of these tumours. Potentially, this finding could be exploited to develop innovative molecular targeted diagnosis and treatment for human nonfunctional pituitary adenomas

Özet

AmAÇ: İnsan hipofiz adenomları intrakraniyal tümörlerin %10'unu oluşturur ve popülasyonun yaklaşık %20'sinde görülür. Hipopitüitarizm veya bölgesel komşu yapıların kompresyonuna yol açarlar. Ancak bu tümörlerin gelişmesine katkıda bulunan moleküler patogenez hakkında çok az bilgi vardır. yÖNTEm ve GEREÇlER: Çalışmada hipofiz adenomlarında folat reseptörü alfa ekspresyonu seviyesi ile bazı klinik faktörler (endokrin, yaş, cinsiyet, tekrarlanan ameliyat olup olmaması, tümörün ortalama çapı ve invaziv olup olmaması) arasındaki ilişki incelendi. Folat reseptörü alfa mRNA'sının hipofiz adenomları ve normal hipofizlerde ekspresyonunu belirlemek üzere gerçek zamanlı floresan kantitatif revers transkriptaz polimeraz zincir reaksiyonu kullanıldı. Folat reseptörü alfa protein seviyeleri Western blot analizi ve immünohistokimya teknikleri kullanımıyla ölçüldü. BulGulAR: Folat reseptörü alfa mRNA ve proteininin fonksiyonel tümörlere göre, klinik olarak nonfonksiyonel hipofiz adenomlarında önemli ölçüde yukarı düzenleme gösterdiğini bulduk. Nonfonksiyonel tümörlerde folat reseptörü alfa ekspresyonu invaziv grupta, noninvaziv gruba göre çok daha yüksekti. soNuÇ: Elde edilen sonuçlar folat reseptörü alfa mRNA ve proteininin nonfonksiyonel pitüiter adenomlar tarafından aşırı ekspresyonunun bu tümörlerin büyümesini kolaylaştırabileceğini düşündürmektedir. Bu bulgu potansiyel olarak insan nonfonksiyonel hipofiz adenomlarının yeni moleküler hedefe yönelik tanı ve tedavilerini geliştirmek üzere kullanılabilir

🔖

Cite This Article

DING, Z., LI, B., WANG, Q., MIAO, Y., LU, X. (2015). ıncrease in Folate receptor Alpha expression in nonfunctional Pituitary Adenomas. Turkish Neurosurgery, Cilt: 25 - Sayı: 2, 298–304. https://ajindex.com/articles/404767

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Asa SL, Ezzat S: The cytogenesis and pathogenesis of pituitary adenomas. Endocr Rev 19: 798-827, 1998 2. Asa SL, Kovacs K: Clinically non-functioning human pituitary adenomas. Can J Neurol Sci 19: 228-235, 1992 3. Basal E, Eghbali-Fatourechi GZ, Kalli KR: Functional folate receptor alpha is elevated in the blood of ovarian cancer patients. PLoS One 4: 6292, 2009 4. Bottero F, Tomassetti A, Canevari S, Miotti S, Menard S, Colnaghi MI: Gene transfection and expression of the ovarian carcinoma marker folate binding protein on NIH/3T3 cells increases cell growth in vitro and in vivo. Cancer Res 53: 5791- 5796, 1993 5. Evans CO, Young AN, Brown MR, Brat DJ, Parks JS, Neish AS, Oyesiku NM: Novel patterns of gene expression in pituitary adenomas identified by complementary deoxyribonucleic acid microarrays and quantitative reverse transcriptionpolymerase chain reaction. J Clin Endocrinol Metab 86: 3097- 3107,2001 6. Evans CO, Reddy P, Brat DJ, O’Neill EB, Craige B, Stevens VL, Oyesiku NM: Differential expression of folate receptor in pituitary adenomas. Cancer Res 63: 4218-4224, 2003 7. Farrell WE, Simpson DJ, Bicknell J, Magnay JL, Kyrodimou E, Thakker RV, Clayton RN: Sequence analysis and transcript expression of the MEN1 gene in sporadic pituitary tumours. Br J Cancer 80: 44-50, 1999 8. Galt JR, Halkar RK, Evans CO, Osman NA, LaBorde D, Fox TH, Faraj BA, Kumar K, Wang H, Oyesiku NM: In vivo assay of folate receptors in nonfunctional pituitary adenomas with 99mTcfolate SPECT/CT. J Nucl Med 51: 1716-1723, 2010 9. Greenman Y, Melmed S: Diagnosis and management of nonfunctioning pituitary tumours. Annu Rev Med 47: 95- 106, 1996 10. Hayashi M, Chernov M, Tamura N, Nagai M, Yomo S, Ochiai T, Amano K, Izawa M, Hori T, Muragaki Y, Iseki H, Okada Y, Takakura K: Gamma Knife robotic microradiosurgery of pituitary adenomas invading the cavernous sinus: Treatment concept and results in 89 cases. Neurooncol 98: 185-194, 2010 11. Hough C, Cho K, Zonderman A, Schwartz D, Morin P: Coordinately up-regulated genes in ovarian cancer. Cancer Res 61: 3869-3876, 2001 12. Katzneson L, Alexander JM, Klibanski A: Clinical review 45: Clinically nonfunctioning pituitary adenomas. J Clin Endocrinol Metab 76: 1089-1094, 1993 13. Levy A: Molecular and trophic mechanisms of tumourigenesis. Endocrinol Metab Clin 37: 23-50, 2008 14. Lubensky IA, Debelenko LV, Zhuang Z, Emmert-Buck MR, Dong Q, Chandrasekharappa S, Guru SC, Manickam P, Olufemi SE, Marx SJ, Spiegel AM, Collins FS, Liotta LA: A